[Amoxapine-induced pseudopheochromocytoma. Apropos of a case].
N
N
Cailleux
I
I
Marie
C
C
Noblet
N D
ND
Moore
L
L
Verdure
H
H
Lévesque
H
H
Courtois
D000310:Adrenal Gland Neoplasms / Q000175:diagnosis*; D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects*; D000368:Aged; D000657:Amoxapine / Q000009:adverse effects*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D000978:Antiparkinson Agents / Q000009:adverse effects; D002230:Carbidopa / Q000009:adverse effects; D003937:Diagnosis, Differential; D004338:Drug Combinations; D004347:Drug Interactions; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D009638:Norepinephrine / Q000378:metabolism; D010673:Pheochromocytoma / Q000175:diagnosis*
D018759:Adrenergic Uptake Inhibitors; D018687:Antidepressive Agents, Second-Generation; D000978:Antiparkinson Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D002230:Carbidopa; D000657:Amoxapine; D009638:Norepinephrine; D004837:Epinephrine
Pseudophéochromocytome induit par l'amoxapine. A propos d'une observation.